CITIUS PHARMAC (Germany) Price on November 19, 2024

47N Stock  EUR 3.29  0.00  0.00%   
If you're considering investing in CITIUS Stock, it is important to understand the factors that can impact its price. As of today, the current price of CITIUS PHARMAC stands at 3.29, as last reported on the 15th of December 2024, with the highest price reaching 3.29 and the lowest price hitting 3.29 during the day. CITIUS PHARMAC DL secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of volatility over the last 3 months. CITIUS PHARMAC DL exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CITIUS PHARMAC's mean deviation of 4.81, and Risk Adjusted Performance of (0.14) to double-check the risk estimate we provide.
  
CITIUS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1957

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns47N

Estimated Market Risk

 7.83
  actual daily
69
69% of assets are less volatile

Expected Return

 -1.53
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.2
  actual daily
0
Most of other assets perform better
Based on monthly moving average CITIUS PHARMAC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CITIUS PHARMAC by adding CITIUS PHARMAC to a well-diversified portfolio.

CITIUS PHARMAC Valuation on November 19, 2024

It is possible to determine the worth of CITIUS PHARMAC on a given historical date. On November 19, 2024 CITIUS was worth 5.01 at the beginning of the trading date compared to the closed value of 5.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CITIUS PHARMAC stock. Still, in general, we apply an absolute valuation method to find CITIUS PHARMAC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CITIUS PHARMAC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CITIUS PHARMAC's related companies.
 Open High Low Close Volume
  4.58    4.58    4.58    4.58    1.00  
11/19/2024
  5.01    5.01    5.01    5.01    1.00  
  4.29    4.78    4.29    4.78    3,138  
Backtest CITIUS PHARMAC  |  CITIUS PHARMAC History  |  CITIUS PHARMAC Valuation   PreviousNext  
Open Value
5.01
5.01
Closing Value
28.50
Upside

CITIUS PHARMAC Trading Date Momentum on November 19, 2024

On November 20 2024 CITIUS PHARMAC DL was traded for  4.78  at the closing time. The highest daily price throughout the period was 4.78  and the lowest price was  4.29 . The daily volume was 3.1 K. The net trading volume on 11/20/2024 added to the next day price reduction. The daily price change to closing price of the next trading day was 4.59% . The overall trading delta to current closing price is 34.33% .

CITIUS PHARMAC DL Fundamentals Correlations and Trends

By evaluating CITIUS PHARMAC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CITIUS PHARMAC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CITIUS financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About CITIUS PHARMAC Stock history

CITIUS PHARMAC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CITIUS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CITIUS PHARMAC DL will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CITIUS PHARMAC stock prices may prove useful in developing a viable investing in CITIUS PHARMAC
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. CITIUS PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10 people.

CITIUS PHARMAC Stock Technical Analysis

CITIUS PHARMAC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CITIUS PHARMAC technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CITIUS PHARMAC trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

CITIUS PHARMAC Period Price Range

Low
December 15, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

CITIUS PHARMAC DL cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

CITIUS PHARMAC December 15, 2024 Market Strength

Market strength indicators help investors to evaluate how CITIUS PHARMAC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CITIUS PHARMAC shares will generate the highest return on investment. By undertsting and applying CITIUS PHARMAC stock market strength indicators, traders can identify CITIUS PHARMAC DL entry and exit signals to maximize returns

CITIUS PHARMAC Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for CITIUS PHARMAC's price direction in advance. Along with the technical and fundamental analysis of CITIUS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CITIUS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for CITIUS Stock analysis

When running CITIUS PHARMAC's price analysis, check to measure CITIUS PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CITIUS PHARMAC is operating at the current time. Most of CITIUS PHARMAC's value examination focuses on studying past and present price action to predict the probability of CITIUS PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CITIUS PHARMAC's price. Additionally, you may evaluate how the addition of CITIUS PHARMAC to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities